Brain amyloid PET scans enhance the diagnosis of Alzheimer's

July 17, 2017

The build-up of amyloid protein in the brain is a hallmark feature of Alzheimer's disease, and its detection often relies on the testing of brain and spinal fluid samples. More recently, PET brain scans have been able to highlight the presence of amyloid in the brain and are extensively used in research studies into Alzheimer's, such as clinical trials for new treatments. However, whether amyloid PET scans provide additional and more accurate information to aid dementia diagnosis is not clear cut, and the high costs associated with the scans (between £1,000-3,000 per scan) have so far limited their wider clinical use. Three studies presented today at the Alzheimer's Association International Conference 2016 are challenging this view.

The first study looked at the addition of PET scans to the battery of tests normally used to diagnose Alzheimer's in Norway, including memory tests and a lumbar puncture to look for Alzheimer's proteins in . Fifty who had been referred to the Oslo University Memory Clinic, Norway, due to problems with their memory underwent the standard range of tests along with a brain amyloid PET scan. The researchers found that the results of the PET scans were a key contributor in arriving as a specific diagnosis or ruling out Alzheimer's.

In the second study, a Swedish research team performed brain amyloid PET scans on people with an unclear . The preliminary results from 61 of the 135 people in the study show that the PET scans resulted in a change in diagnosis in 68% of study participants. The team also found results from brain and spinal fluid conflicted with those from the PET scans, with the results agreeing 53-57% of the time. Spinal fluid amyloid tests are not used in routine clinical diagnosis of dementia in the UK.

The third study led by GE Healthcare in the UK analysed data from four previous studies looking at the use of brain amyloid PET scans in the process of dementia diagnosis, combining information from 1106 people. The analysis revealed that the use of brain amyloid PET scans led to a change in diagnosis in 20% of people, indicating Alzheimer's disease as the underlying cause in some people, while ruling it out in others.

Dr David Reynolds, Chief Scientific Officer at Alzheimer's Research UK said:

"Diagnosing dementia is a complex challenge, and doctors have to gather a range of clues to create a picture of what is going on in the brain. Brain amyloid PET scans offer a different insight into brain changes in dementia, showing the presence of amyloid in the brain indicative of Alzheimer's. Although lack of a positive scan can rule out Alzheimer's, the fact that cognitively normal older people can also have a positive scan makes their interpretation more difficult. This new research highlights the value that amyloid brain scans can bring in helping doctors make a more informed diagnosis, either by indicating or ruling out Alzheimer's as the possible cause of someone's dementia symptoms.

"Amyloid PET scans carry a high price tag, and their use in the UK is mainly limited to research studies and , to ensure that potential new medicines are tested on the right people. The current drive for life-changing dementia treatments means that in the future, the use of amyloid PET scans or other innovative diagnostic methods will be important to ensure that new medicines reach the right people at the right time. Alzheimer's Research UK is working with government and policy makers to ensure that the health service is set up to allow patients and doctors to benefit from innovations in diagnosis and treatment as research into continues to progress."

Explore further: Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Related Stories

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

June 14, 2017
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major symptoms arise is critical to preserving brain function and helping patients maintain quality of life. ...

Promising new methods for early detection of Alzheimer's disease

July 8, 2016
New methods to examine the brain and spinal fluid heighten the chance of early diagnosis of Alzheimer's disease. Results from a large European study, led by researchers at the Karolinska Institutet, are now published in the ...

Is it Alzheimer's disease or another dementia? Marker may give more accurate diagnosis

November 30, 2011
New research finds a marker used to detect plaque in the brain may help doctors make a more accurate diagnosis between two common types of dementia – Alzheimer's disease and frontotemporal lobar degeneration (FTLD). ...

Memory loss not enough to diagnose Alzheimer's

September 13, 2016
Relying on clinical symptoms of memory loss to diagnose Alzheimer's disease may miss other forms of dementia caused by Alzheimer's that don't initially affect memory, reports a new Northwestern Medicine study.

Amyloid pet may lead to better treatment for Alzheimer's patients

June 8, 2015
New research presented during the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates that amyloid positron emission tomography (amyloid PET) scans of the brain provide clearer ...

Findings support role of vascular disease in development of Alzheimer's disease

April 11, 2017
Among adults who entered a study more than 25 years ago, an increasing number of midlife vascular risk factors, such as obesity, high blood pressure, diabetes, high cholesterol and smoking, were associated with elevated levels ...

Recommended for you

Multi-gene test predicts Alzheimer's better than APOE E4 alone

September 22, 2017
A new test that combines the effects of more than two dozen genetic variants, most associated by themselves with only a small risk of Alzheimer's disease, does a better job of predicting which cognitively normal older adults ...

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

September 20, 2017
Nearly a quarter century ago, a genetic variant known as ApoE4 was identified as a major risk factor for Alzheimer's disease—one that increases a person's chances of developing the neurodegenerative disease by up to 12 ...

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

Researchers unlock the molecular origins of Alzheimer's disease

September 6, 2017
A "twist of fate" that is minuscule even on the molecular level may cause the development of Alzheimer's disease, VCU researchers have found.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.